Can zinc depletion play a role in LEV-induced hair loss? Considerations from a case study

Epilepsy and Behavior

Volumn 29, Issue 1, 2013, Pages 254-255

  Calabrò, Rocco Salvatore ^a   Bramanti, Placido ^a   Spina, Edoardo ^b   Italiano, Domenico ^b  

^a IRCCS CENTRO NEUROLESI BONINO PULEJO   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ETIRACETAM; TOPIRAMATE; ZINC;

ADULT; ALOPECIA; BLOOD EXAMINATION; CASE REPORT; CASE STUDY; CLINICAL FEATURE; DEPLETION; DRUG DOSE TITRATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HAIR GROWTH; HUMAN; LETTER; OUTCOME ASSESSMENT; SKIN EXAMINATION; TONIC CLONIC SEIZURE; TREATMENT RESPONSE; ZINC BLOOD LEVEL;

ADULT; ANTICONVULSANTS; EPILEPSY, TONIC-CLONIC; FEMALE; HAIR DISEASES; HEMATOLOGIC TESTS; HUMANS; PIRACETAM; ZINC;

EID: 84883810299     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2013.06.032     Document Type: Letter

References (6)

1. Mercke Y., Sheng H., Khan T., Lippmann S. Hair loss in psychopharmacology. Ann Clin Psychiatry 2000, 12:35-42.
2. Castro-Gago M., Pérez-Gay L., Gómez-Lado C., Castiñeiras-Ramos D.E., Otero-Martínez S., Rodríguez-Segade S. The influence of valproic acid and carbamazepine treatment on serum biotin and zinc levels and on biotinidase activity. J Child Neurol 2011, 26:1522-1524.
3. Eker H.E., Cok O.Y., Aribogan A. Alopecia associated with gabapentin in the treatment of neuropathic pain. J Pain Symptom Manage 2009, 37:5-6.
4. Hillemacher T., Bleich S., Kornhuber J., Frieling H. Hair loss as a side effect of lamotrigine treatment. Am J Psychiatry 2006, 163:1451.
5. Finner A.M. Nutrition and hair: deficiencies and supplements. Dermatol Clin 2013, 31:167-172.
6. Rigo J.M., Hans G., Nguyen L., Rocher V., Belachew S., Malgrange B., et al. The anti-epileptic drug levetiracetam reverses the inhibition by negative allosteric modulators of neuronal GABA- and glycine-gated currents. Br J Pharmacol 2002, 136:659-672.